Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
13.88
-0.08 (-0.57%)
At close: Mar 5, 2026, 4:00 PM EST
13.88
0.00 (0.00%)
After-hours: Mar 5, 2026, 4:10 PM EST
Jade Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Jade Biosciences stock have an average target of 22.6, with a low estimate of 17 and a high estimate of 28. The average target predicts an increase of 62.82% from the current stock price of 13.88.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 7, 2026.
Analyst Ratings
The average analyst rating for Jade Biosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +80.12% | Jan 7, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +80.12% | Nov 25, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $14 → $17 | Strong Buy | Maintains | $14 → $17 | +22.48% | Nov 18, 2025 |
| BTIG | BTIG | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +101.73% | Oct 9, 2025 |
| Wedbush | Wedbush | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +29.68% | Aug 14, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.98
from -18.79
EPS Next Year
-1.95
from -2.98
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.45 | -1.36 | |
| Avg | -2.98 | -1.95 | |
| Low | -3.53 | -2.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.